VistaGen Therapeutics (VSTA) Stands to Benefit from Unprecedented, Long Overdue Shift in Pharmaceutical Industry
There’s a pivotal shift taking place the pharmaceutical industry, one that bridges the gap between the company with an $80 billion market cap and heavy cash flow and the one with an $8 million market cap scraping the bottom of the barrel. That bridge is called public market, and by connecting the landmass (market space, in this case) of both companies, there is considerable and growing symmetry in the balance of power between the pharmaceutical giants and the little guys. In an interesting article entitled, “The Big Guys Have Lost Their Iron Grip, and It’s All Good,” author Luke Timmerman…